CoChat

Predictors of mortality and end‐stage diabetic complications in patients with Type 1 diabetes mellitus on intensified insulin therapy

Mühlhauser, I., Overmann, H., Bender, R., Jörgens, V., Berger, M. · 2000 · Diabetic Medicine
Cited by 83

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

SUMMARY Aims To assess predictors of mortality and end‐stage diabetic complications in patients with Type 1 diabetes mellitus on intensified insulin therapy. Methods A cohort of 3674 patients (insulin treatment before age 31) who had participated in a 5‐day in‐patient group treatment and teaching programme for intensification of insulin therapy between 9/1978 and 12/1994 were re‐assessed after 10 ± 3 (mean ± sd) years. Results Vital status and data on blindness, amputations, and renal replacement therapy were documented for 97% patients; 7% patients had died, 1.3% had become blind, 2% had amputations and 4.6% started renal replacement therapy. Using the Cox proportional hazards model, the following risk factors of mortality as assessed at baseline were identified: nephropathy (at least macroproteinuria), hazard ratio 3.8 (95% confidence interval 2.6–5.6); smoking, 1.9 (1.4–2.6); diabetes duration, 1.5 (1.2–1.8) for a difference of 10 years; serum cholesterol, 1.1 (1.0–1.2) for a difference of 1 mmol/l; lower social status, 1.4 (1.1–1.8) for a difference of 1 out of 3 levels; age, 1.3 (1.1–1.6) for a difference of 10 years; male sex, 1.4 (1.1–1.9); systolic blood pressure, 1.1 (1–1.2) for a difference of 10 mmHg. For the combined endpoint – blindness or amputations or renal replacement therapy – predictors were: nephropathy, foot complications, HbA 1c, smoking, cholesterol, systolic blood pressure, retinopathy, hypertension, and social status. Conclusion In Type 1 diabetic patients who start intensified insulin therapy, nephropathy remains the strongest predictor of mortality and end‐stage complications. Glycosylated haemoglobin is a risk factor of end‐stage complications but not of mortality. Conventional risk factors comparable to the general population, particularly smoking become operative as predictors of both mortality and end‐stage complications.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1464-5491.2000.00372.x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 83

Metadata

Authors
Mühlhauser, I., Overmann, H., Bender, R., Jörgens, V., & Berger, M.
Venue
Diabetic Medicine
Publisher
Wiley
Published
2000-10
Volume
17
Issue
10
Pages
727-734
ISSN
  • 0742-3071 (ISSN-L)
  • 1464-5491
OpenAlex
W2079927591
Cited by
83
References
2
FWCI
3.06
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Predictors of mortality and end‐stage diabetic complications in patients with Type 1 diabetes mellitus on intensified insulin therapy. https://app.cochat.ai/papers/10.1046/j.1464-5491.2000.00372.x
The paper
Mühlhauser, I., Overmann, H., Bender, R., Jörgens, V., & Berger, M. (2000). Predictors of mortality and end‐stage diabetic complications in patients with Type 1 diabetes mellitus on intensified insulin therapy. Diabetic Medicine. https://doi.org/10.1046/j.1464-5491.2000.00372.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.